Hepabig 100 IU Injection is a human hepatitis B immunoglobulin (HBIG) product used to provide temporary protection against hepatitis B virus (HBV) infection in specific clinical situations. It contains antibodies that can help provide immediate, short-term passive immunity when exposure to hepatitis B may have occurred or when protection is required according to a healthcare professional’s assessment.
For hospitals, healthcare providers, pharmaceutical distributors, and international buyers looking for information about Hepabig 100 IU Injection, understanding its medical use, administration, precautions, and storage requirements is important.
What Is Hepabig 100 IU Injection?
Hepabig 100 IU Injection contains Human Hepatitis B Immunoglobulin, which provides antibodies against hepatitis B virus. Unlike hepatitis B vaccination, which stimulates the body's immune system to develop its own longer-term immune response, HBIG provides antibodies that are available immediately.
The injection is generally used under medical supervision in situations where rapid passive protection against HBV is considered necessary.
What Is Hepabig 100 IU Injection Used For?
Hepabig 100 IU Injection is primarily associated with post-exposure protection against hepatitis B. Its use may be considered following certain exposures to hepatitis B-positive or potentially infectious blood or body fluids, depending on the circumstances and applicable medical guidelines.
HBIG may also be used in selected situations involving prevention of hepatitis B recurrence after liver transplantation or other specialized clinical circumstances, according to the treatment protocol prescribed by a specialist.
The exact indication, dose, timing, and duration of treatment depend on factors such as the type of exposure, the person's hepatitis B vaccination and immunity status, and the healthcare professional’s assessment.
Hepabig 100 IU Injection After Hepatitis B Exposure
When a person has potentially been exposed to HBV, prompt medical evaluation is important. Depending on the exposure and the individual's vaccination or antibody status, a healthcare professional may recommend hepatitis B immunoglobulin, hepatitis B vaccination, or both.
HBIG works by supplying ready-made antibodies against HBV. Because protection from immunoglobulin is temporary, vaccination may be recommended separately when appropriate to establish longer-lasting immunity.
Treatment decisions should be made as soon as possible after exposure because the timing of preventive intervention can affect its usefulness.
How Is Hepabig 100 IU Injection Given?
Hepabig 100 IU Injection should be administered by a qualified healthcare professional. The route of administration and dose depend on the specific clinical indication and treatment protocol.
Patients should not self-administer this medicine. Healthcare professionals determine the appropriate dosage based on the patient's circumstances, product instructions, and applicable clinical recommendations.
Hepabig 100 IU Injection Side Effects
Like other human immunoglobulin products, Hepabig may cause side effects in some individuals. Possible reactions can include:
- Pain, redness, or discomfort at the injection site
- Headache
- Fever or chills
- Nausea
- Fatigue
- Mild allergic reactions
Serious allergic or hypersensitivity reactions are uncommon but require immediate medical attention. Anyone experiencing difficulty breathing, swelling, severe dizziness, or other signs of a serious allergic reaction should seek urgent medical care.
Important Precautions
Before receiving Hepabig 100 IU Injection, patients should inform their healthcare professional about any known allergies, previous reactions to immunoglobulin products, current medicines, and relevant medical history.
Because immunoglobulin products are derived from human plasma, they are manufactured and tested using processes designed to reduce the risk of transmission of infectious agents. However, patients and healthcare providers should follow the manufacturer's prescribing information and applicable safety guidance.
Hepabig should be handled and stored according to the manufacturer's recommended temperature and storage conditions. Healthcare facilities and pharmaceutical distributors should maintain appropriate cold-chain or controlled-storage procedures where required by the product labeling.
Hepabig 100 IU Injection for Hospitals and Pharmaceutical Buyers
Hospitals, clinics, pharmaceutical distributors, and healthcare procurement teams may require a reliable supply of Hepabig 100 IU Injection for approved clinical use. Buyers should verify product availability, batch information, packaging, regulatory requirements, and import documentation before placing an international order.
For pharmaceutical procurement from India, buyers should work with an appropriate licensed supplier or exporter and confirm that the product can legally be imported into the destination country.
Why Choose Global Pharma Trade?
Global Pharma Trade is a pharmaceutical exporter from India serving international buyers seeking pharmaceutical products and healthcare supplies. For enquiries related to Hepabig 100 IU Injection, buyers can contact the company to check product availability, specifications, export requirements, and quotation details.
International buyers should provide their destination country, required quantity, and relevant procurement information when requesting a quotation.
Frequently Asked Questions About Hepabig 100 IU Injection
1. What is Hepabig 100 IU Injection used for?
Hepabig 100 IU Injection is a hepatitis B immunoglobulin product used to provide temporary passive protection against hepatitis B in specific clinical situations, including certain post-exposure circumstances.
2. Does Hepabig treat hepatitis B?
Hepabig is primarily used to provide passive antibodies and prevention in appropriate clinical situations. It is not generally considered a standalone treatment for chronic hepatitis B infection.
3. Can Hepabig be given after hepatitis B exposure?
A healthcare professional may recommend HBIG after certain HBV exposures, depending on the exposure circumstances and the person's vaccination and immunity status.
4. Is Hepabig the same as hepatitis B vaccine?
No. Hepabig provides ready-made antibodies for temporary protection, while hepatitis B vaccination stimulates the immune system to develop longer-lasting protection.
5. Who can supply Hepabig 100 IU Injection internationally?
Licensed pharmaceutical exporters and suppliers may supply the product subject to the regulations of the exporting and importing countries. Buyers should verify all applicable regulatory and import requirements.
Conclusion
Hepabig 100 IU Injection is an important human hepatitis B immunoglobulin product used in selected situations where rapid, temporary passive protection against HBV is required. Its use is particularly relevant to certain hepatitis B exposure scenarios and specialized medical protocols. The appropriate dose, timing, administration, and combination with hepatitis B vaccination should always be determined by a qualified healthcare professional.
For pharmaceutical distributors, hospitals, and international buyers, confirming product availability, regulatory requirements, storage conditions, and documentation is essential before procurement.
